Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma (Q40102250)

17 September 2017

title

Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma (English)

1 reference

17 September 2017

1 reference

10

1 reference

17 September 2017

6

0 references

author name string

Yen-Shen Lu

1

1 reference

17 September 2017

Yoko Kashida

2

1 reference

17 September 2017

Samuel K Kulp

3

1 reference

17 September 2017

Yu-Chieh Wang

4

1 reference

17 September 2017

Dasheng Wang

5

1 reference

17 September 2017

Monica Tang

7

1 reference

17 September 2017

Zhong-Zhe Lin

8

1 reference

17 September 2017

Te-Jung Chen

9

1 reference

17 September 2017

Ching-Shih Chen

11

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

46

1 reference

17 September 2017

issue

4

1 reference

17 September 2017

page(s)

1119-1130

1 reference

Inhibitors of histone deacetylase as new anticancer agents

17 September 2017

cites work

1 reference

Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma: are we making progress?

21 January 2018

1 reference

7 January 2021

Opportunities for targeted therapies in hepatocellular carcinoma

1 reference

7 January 2021

Hepatocellular carcinoma: overcoming challenges in disease management

1 reference

7 January 2021

Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity

1 reference

7 January 2021

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

7 January 2021

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

7 January 2021

Hepatocellular carcinoma: current management and future trends.

1 reference

7 January 2021

Novel systemic therapy options for hepatocellular carcinoma

1 reference

7 January 2021

Pathogenesis of hepatocellular carcinoma

1 reference

7 January 2021

Liver pathology in obesity

1 reference

7 January 2021

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

1 reference

7 January 2021

Histone deacetylase inhibitors open new doors in cancer therapy

1 reference

7 January 2021

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

7 January 2021

The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells

1 reference

7 January 2021

Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes

1 reference

7 January 2021

Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells

1 reference

7 January 2021

Sensitizing to apoptosis--sharpening the medical sword

1 reference

7 January 2021

Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells

1 reference

7 January 2021

Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells.

1 reference

7 January 2021

Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.

1 reference

7 January 2021

SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma

1 reference

7 January 2021

Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin

1 reference

7 January 2021

Histone deacetylase inhibitors: understanding a new wave of anticancer agents

1 reference

7 January 2021

Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

1 reference

7 January 2021

Targeting histone deacetylase in cancer therapy

1 reference

7 January 2021

Duration of nuclear NF-kappaB action regulated by reversible acetylation

1 reference

7 January 2021

Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation

1 reference

7 January 2021

Stat3 dimerization regulated by reversible acetylation of a single lysine residue

1 reference

7 January 2021

Post-translational modification of p53 in tumorigenesis

1 reference

7 January 2021

Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.

1 reference

7 January 2021

Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824.

1 reference

7 January 2021

Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes

1 reference

7 January 2021

Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors

1 reference

7 January 2021

Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer

1 reference

7 January 2021

Expression and role of Bcl-xL in human hepatocellular carcinomas

1 reference

7 January 2021

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

7 January 2021

Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging

1 reference

7 January 2021

Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis

1 reference

7 January 2021

In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer

1 reference

7 January 2021

Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer

1 reference

7 January 2021

Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.

1 reference

7 January 2021

Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21804

1 reference

17 September 2017

1 reference